Obesity associated immune alterations also provide targets for therapy; M2 polarisation of macrophages can be prevented by specific inhibitors and apoptosis of obesity associated MDSC populations in the TME can be induced by liver X receptor-β (LXRβ) agonists (110, 119). Here, NR1H2 is linked to obesity disorder.